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Abstract
Class I major histocompatibility complex (MHC I) molecules are transmembrane proteins that bind and present peptides
to T-cell antigen receptors. The role of membrane lipids in controlling MHC I structure and function is not understood,
although membrane lipid composition influences cell surface expression of MHC I. We reconstituted liposomes with purified
MHC I (Kb) and probed the effect of lipid composition on MHC I structure (monoclonal anti-MHC I antibody binding).
Four phospholipids were compared; each had a phosphocholine head group, stearic acid in the sn-1 position, and either
oleic, K-linolenic, arachidonic, or docosahexaenoic acid (DHA) in the sn-2 position. The greatest binding of monoclonal
antibody AF6-88.5, which detects a conformationally sensitive epitope in the extracellular region of the MHC I K-chain, was
achieved with DHA-containing proteoliposomes. Other epitopes (CTKb, 5041.16.1) showed some sensitivity to lipid
composition. The addition of L2-microglobulin, which associates non-covalently with the K-chain and prevents K-chain
aggregation, did not equalize antibody binding to proteoliposomes of different lipid composition, suggesting that free
K-chain aggregation was not responsible for disparate antibody binding. Thus, DHA-containing membrane lipids may
facilitate conformational change in the extracellular domains of the K-chain, thereby modulating MHC I function through
effects on that protein’s structure. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Class I major histocompatibility complex (MHC I)
molecules are membrane glycoproteins found on the
surface of all nucleated cells. Their principal function
is to present antigen peptides to T-lymphocytes, a
task that is accomplished when a heterotrimer com-
posed of the V45-kDa MHC I K-chain, a non-co-
valently associated 12-kDa L2-microglobulin (L2m)
protein, and peptide interacts with the antigen recep-
tor (TCR) on T-cells (Fig. 1). If the interaction is
su⁄ciently avid, the antigen-speci¢c T-cell becomes
activated. Our current understanding of the molecu-
lar interaction between the TCR and MHC I trimer
is that the peptide provides one set of contacts with
the TCR, and that several critical amino acid resi-
dues of the MHC I K-chain also contact the TCR [1],
and hence the conformation of the K-chain is
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thought to contribute substantially to TCR interac-
tion [2].
MHC I functions naturally while spanning the bi-
layer of the plasma membrane, and thus it is impor-
tant to ask whether membrane lipids may control
MHC I structure and thereby ¢ne tune T-cell activa-
tion. Recently, three-dimensional structure was de-
termined for membrane-bound murine MHC I, i.e.
soluble MHC I whose transmembrane and cytoplas-
mic regions were replaced by a histidine tag to an-
chor the molecule in a monolayer of nickel-chelating
lipids [3]. The extracellular domains of MHC I ap-
pear positioned such that L2m contacts the lipid
layer and the peptide binding groove is directed
away from the lipid surface toward the TCR. How-
ever, little else is known about the relationship be-
tween membrane lipids and MHC I structure and
function. We have directed our e¡orts to exploring
how the omega-3 fatty acid docosahexaenoic acid
(DHA, 22:6g3), an important dietary component
that becomes incorporated into membrane phospho-
lipids, may control MHC I properties.
Lateral mobility, clustering, internalization, and
protein conformation are critical properties of
MHC I molecules to examine for lipid modulation.
Lateral mobility of MHC I transmembrane proteins
is limited by the proteins’ interactions with cytoskel-
etal components, rather than by membrane lipids as
is the case for a few proteins, such as visual rhodop-
sin [4]. Similarly, clustering of MHC I may not be
driven directly by membrane lipid composition. That
is, self aggregates of MHC I appear to result from
loss or lack of L2m [5^9] and do not correlate with
lipid domains detectable in plasma membranes [6].
Aggregation may serve to promote internalization
of free K-chains [8,10], thereby removing conforma-
tionally altered MHC I from the cell surface. Mem-
brane protein conformation, on the other hand, is
in£uenced by membrane lipids. For example, mem-
brane lipids alter the apparent pK for the conforma-
tional equilibrium of metarhodopsin IHmetarho-
dopsin II [11] ; DHA-containing phospholipids
favor this conformational change purportedly by in-
ducing negative curvature stress in membranes [12].
In the case of calcium ATPase, conformational
changes associated with catalytic activity are a¡ected
by alterations in membrane phospholipid composi-
tion [13], and several indicators of K-fetoprotein con-
formation (number of estradiol binding sites, estra-
diol equilibrium dissociation constant, UV
absorption spectrum, and monoclonal antibody reac-
tivity) varied with the concentration of free DHA
[14]. Albeit limited, there do exist provocative data
implicating the membrane and membrane lipids in
controlling MHC I conformation. Bene et al. [15]
used intramolecular £uorescence resonance energy
transfer (FRET) to detect a conformational change
in MHC I induced by depolarization of JY (B-lym-
phoblastoid) cells, and proposed that physical
changes in membrane lipids may mediate, directly
or indirectly, MHC I’s conformational change. Bind-
ing of monoclonal antibodies to MHC I on normal
mouse lymphocytes is decreased by treatment of the
cells with cholesterol hemisuccinate (which increases
lipid packing), and increased by a PC preparation
(which decreases lipid packing) [16]. Similarly, cho-
lesterol enrichment augments the self-aggregation
and reduces the expression of human MHC I on
JY cells, whereas cholesterol depletion, which £uid-
izes the membrane, enhances MHC I expression [17].
Fig. 1. Cartoons of MHCI in the native and hairpin con¢gura-
tions. The K-chain consists of the K1-, K2-, and K3-domains,
transmembrane region, and cytoplasmic tail. The intact hetero-
trimeric MHCI molecule includes, in addition to the K-chain,
the L2m-protein, and a peptide bound in the groove formed by
the K1- and K2-domains. In the hairpin con¢guration, the
transmembrane region fails to span the bilayer, i.e. remains in
the outer lea£et, causing the cytoplasmic tail to emerge on the
‘extracellular’ side of the bilayer. The locations of the two free
sulfhydryl groups (cysteines) available for IAEDANS labeling
are indicated by arrows.
BBAMEM 77889 9-8-00
L.J. Jenski et al. / Biochimica et Biophysica Acta 1467 (2000) 293^306294
We have incorporated DHA, esteri¢ed to PC, di-
rectly into the plasma membrane of viable cells and
detected altered surface MHC I expression as moni-
tored by monoclonal antibody binding and recogni-
tion by cytotoxic T-lymphocytes [18]. DHA is the
longest (22 carbons) and most unsaturated (six dou-
ble bonds) fatty acid found in abundance in biolog-
ical systems, and there is substantial evidence to
suggest that DHA-containing phospholipids dramat-
ically alter membrane properties, such as domain
formation, fusion, and permeability [19^21]. That
we found DHA to di¡erentially a¡ect two distinct
MHC I epitopes, one epitope increased and one de-
creased as the membrane’s DHA content rose [18],
indicated not a global loss of this membrane protein,
but rather a DHA-induced change in MHC I con-
formation or spatial distribution (steric hindrance).
To demonstrate that DHA-containing phospholipids
directly alter a physical property of MHC I (that
monitored by binding of monoclonal antibodies),
we have isolated murine MHC I protein, reconsti-
tuted liposomes of various phospholipid composi-
tions, and with £ow cytometry analyzed MHC I epi-
tope accessibility in di¡erent lipid environments. Our
results provide direct evidence that DHA-containing
phospholipids present in the milieu of this membrane
protein a¡ect some physical property, most likely
conformation, in turn altering the binding of mono-
clonal antibodies to epitopes in extracellular protein
domains. We predict that DHA-induced changes
may ultimately a¡ect MHC I interactions with pep-
tide and TCR, and thereby modulate the activation
of T-cells and the outcome of immune responses.
2. Materials and methods
2.1. Cells
The murine T-cell lymphoma EL4 was obtained
from the American Type Culture Collection
(ATCC, Rockville, MD). The cells were cultured in
serum-free medium HyQ CCM-1 (HyClone Labs,
Logan, UT) supplemented with 100 U penicillin/ml,
100 Wg streptomycin/ml, and 2 mM glutamine. These
culture conditions preserved endogenous murine
L2m, i.e. circumvented exchange with serum bovine
L2m. Cultures were terminated when the cell density
reached V8U105 cells/ml and viability was still
v90%. Harvested cells were washed twice in cold
phosphate-bu¡ered saline (PBS) and stored as a pel-
let at 380‡C.
2.2. Monoclonal antibodies
The hybridoma M1/42.3.9.8 (M1/42; anti-mouse
MHC I, all haplotypes) was purchased from ATCC
and grown in HyQ CCM-1 medium to con£uency.
IgG was isolated from culture supernatant by a⁄nity
chromatography on Protein G^Sepharose (Sigma, St.
Louis, MO). A⁄nity-puri¢ed M1/42 antibodies were
covalently linked to CNBr-activated Sepharose 4B
(2.2 mg protein/ml Sepharose) as recommended by
the manufacturer (Amersham Pharmacia Biotech,
Pistcataway, NJ). The hybridoma 28-14-8S (anti-
LdDb), also purchased from ATCC, was grown in
RPMI 1640 medium supplemented with antibiotics,
2 mM glutamine, 25 mM HEPES bu¡er, and 10%
bovine calf serum; IgG was isolated from culture
supernatant by a⁄nity chromatography on goat
anti-mouse IgG-Sepharose (Cappel/Organon Tekni-
ka, West Chester, PA). Fluorophore-conjugated
monoclonal antibody AF6-88.5 (anti-Kb) was pur-
chased from PharMingen (San Diego, CA), and £u-
orescein (FITC)-labeled CTKb (anti-Kb) and
5041.16.1 (anti-KbDb) were obtained from Cedarlane
(Accurate, Westbury, NY). FITC-goat anti-mouse
IgG was purchased from Kirkegaard and Perry (Gai-
thersburg, MD).
2.3. Immunoa⁄nity isolation of MHC I
Frozen EL4 cell pellets were thawed in a 37‡C
water bath and resuspended in cold PBS to which
an equal volume of concentrated lysis bu¡er was
added such that the ¢nal suspension equaled
5U107 cells/ml of 0.5% NP40, 20 mM Tris, pH 8.0,
140 mM NaCl, and 1.5 mM phenylmethanesulfonyl
£uoride. After incubation on ice for 20^25 min, the
lysate was centrifuged for 15 min at 4‡C at
2400Ugmax, and that supernatant centrifuged for
45 min at 4‡C at 165 000Ugmax. The ¢nal superna-
tant was diluted ¢ve-fold with ice-cold water to re-
duce the detergent concentration, and supplemented
to achieve 1.5 mM phenylmethanesulfonyl £uoride.
The lysate was loaded onto a 10-ml column of non-
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immune IgG2a (Sigma, St. Louis, MO) coupled to
Sepharose 4B, and the unbound £ow through was
channeled directly to the 1-ml M1/42 a⁄nity column
at a £ow rate of 30 ml/h. The a⁄nity column was
washed with 20 column volumes of pre-elution bu¡er
(0.5% deoxycholate, 140 mM NaCl, 15 mM Tris, pH
8.0) and bound MHC I was eluted with 20 column
volumes of elution bu¡er (21 mM n-octyl-K-D-gluco-
pyranoside, 20 mM NaHCO3, pH 11.5) at 4‡C at
0.5^1.0 ml/min. One-milliliter fractions of both the
pre-elution wash and eluant were bu¡ered with
100 Wl of 1 M Tris, pH 8.0, and saved for protein
and PAGE analyses. Protein analysis was conducted
with a BCA protein assay kit (Pierce, Rockford, IL)
as described by the manufacturer. Protein in samples
for SDS^PAGE was precipitated with cold 12.5%
trichloroacetic acid and pelleted by centrifugation
at 7800Ugmax for 15 min at room temperature. The
pellets were washed twice with ice-cold acetone to
remove residual detergent, dissolved in sample bu¡er
(1^4 Wg protein/20 Wl bu¡er), heated to 100‡C for
5 min, and electrophoresed by the method of
Laemmli [22]. The gels were stained either with
0.3% w/v Coomassie brilliant blue R-250 or with a
silver stain kit (Boehringer Mannheim Biochemicals/
Roche, Indianapolis, IN).
2.4. Construction of MHC I proteoliposomes
The following phospholipids were purchased from
Avanti Polar Lipids (Alabaster, AL): 1-stearoyl, 2-
oleoyl-phosphatidylcholine (18:0, 18:1 PC), 1-stearo-
yl, 2-K-linolenoylphosphatidylcholine (18:0, 18:3
PC), 1-stearoyl, 2-arachidonoylphosphatidylcholine
(18:0, 20:4 PC), 1-stearoyl, 2-docosahexaenoylphos-
phatidylcholine (18:0, 22:6 PC), and egg PC. Solvent
was evaporated from the lipids under a stream of
nitrogen followed by vacuum pumping, and the lip-
ids were rehydrated to 1 mg/ml of 20 mM NaHCO3,
pH 9, for 10 min at room temperature with frequent
vortexing. The lipids were then extruded v10 times
through a 2-Wm Nucleopore membrane (Nucleopore
Filtration Products, Pleasanton, CA) using a syringe-
type extruder (Avestin, Ottawa, Canada). Puri¢ed
MHC I (2 Wg) was added to 20 Wg of 2-Wm liposomes
and 13 mM n-octyl-K-D-glucopyranoside (¢nal con-
centration) in a total volume of 300 Wl. The n-octyl-
K-D-glucopyranoside concentration corresponds to
that required to saturate, but not solubilize, the lipo-
somes, and was determined empirically as described
by Rigaud et al. [23]. After 1 min at room temper-
ature, complete and rapid detergent removal was
achieved with 80 mg of degassed SM-2 Bio-Beads/
ml (Bio-Rad, Hercules, CA) for 3 h with agitation in
the dark at room temperature followed by a 1-h in-
cubation with a fresh aliquot of Bio-Beads [23].
2.5. Flow cytometry
Proteoliposomes (2 Wg of protein in 300 Wl total
volume) were incubated with 1 Wg of £uorescently
labeled anti-MHC I monoclonal antibodies for
30 min at room temperature in the dark. Cytometry
was accomplished with a Coulter Epics Elite ESP cell
sorter equipped with an argon laser. Antibody bind-
ing to liposomes, i.e. £uorescence, is described in two
ways: the mean and median £uorescence intensity
channels (range, 0^1023), and the percent of lipo-
somes having a given £uorescence intensity. In the
latter case, £uorescence intensities are divided into
four levels corresponding to the four decades (sets
of 256 channels) of the log scale on a 1024-channel
photomultiplier tube. The gating of forward versus
side scatter histograms, to select comparable proteo-
liposomes for analysis, is shown in the ¢gures. Expo
2.0 software (Beckman Coulter, Fullerton, CA) was
used for data analysis and exportation for the crea-
tion of graphics.
2.6. Assessment of native vs. hairpin con¢guration
The £uorescent sulfhydryl probe 5-((((2-iodoace-
tyl)amino)ethyl)amino)naphthalene-1-sulfonic acid
(IAEDANS, Molecular Probes, Eugene, OR), was
used to label the two free sulfhydryl groups (Cys-
142, Cys-358) present on the MHC I K-chain [24].
IAEDANS (4.3 mg) was dissolved in 1 ml of dimeth-
ylsulfoxide, added to 2 Wg of puri¢ed MHC I, and
mixed gently for 1 h at room temperature in the
dark. An excess (105 Wl) of 2-mercaptoethanol was
added to the sample to consume unbound IAE-
DANS and the sample was dialyzed for 24 h against
1.38 mM n-octyl-K-D-glucopyranoside, 20 mM
NaHCO3, pH 9 (three changes) in a 100^500 Wl
Slide-A-Lyzer dialysis cassette (Pierce, Rockford,
IL). The labeled MHC I was then inserted into the
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preformed 2-Wm liposomes as described above for
the construction of proteoliposomes. Proteolipo-
somes were diluted and placed into an LS50B £uo-
rimeter (Perkin Elmer, Norwalk, CT) and excited at
350 nm; £uorescence emission was monitored from
360 to 600 nm, and then CoCl2 (29^50 mM ¢nal
concentration) was added to quench [Cys-142]-
AEDANS £uorescence from the external surface of
the proteoliposomes. Finally, 0.3% Triton X-100
(¢nal concentration) was added to solubilize all pro-
teoliposomes and allow quenching of [Cys-358]-
AEDANS in the liposomes’ interior.
2.7. Human L2m addition
MHC I proteoliposomes (2 Wg protein in 300 Wl
total volume) were incubated with 30 Wl of 0.22-Wm
¢ltered human serum (Sigma) or 10 Wl of a 0.1 mg/ml
solution of puri¢ed human L2m (Sigma) for 1 h at
room temperature. After incubation, 1 Wg of FITC-
labeled monoclonal anti-Kb (clone AF6-88.5) was
added, and the proteoliposomes were incubated for
30 min at room temperature in the dark and then
analyzed by £ow cytometry.
2.8. Indirect staining of cells and proteoliposomes for
£ow cytometry
To assess whether Db was present in the MHC I
protein used for proteoliposome reconstitution, 1 Wg
of anti-Db (28-14-8S), puri¢ed from hybridoma
culture supernatant as described previously in Sec-
tion 2, was incubated for 30 min at room temper-
ature with proteoliposomes containing 2 Wg of MHC
I protein and with 1U106 live EL4 cells (the original
cell source of the MHC I). A secondary FITC-la-
beled anti-mouse IgG antibody was added in 5-fold
molar excess, and after an additional 30-min incuba-
tion at room temperature, the cells and proteolipo-
somes were analyzed for £uorescence by £ow cyto-
metry.
2.9. Statistical methods
The Wilcoxon paired sample test was used to as-
sess signi¢cant di¡erences between antibody binding
to proteoliposomes of di¡erent phospholipid compo-
sition. A non-parametric test was necessary because
proteoliposome £uorescence intensities were not nor-
mally distributed. To accommodate day-to-day var-
iations introduced with di¡erent MHC I puri¢cation
lots, proteoliposome preparation, and instrument
performance, the statistical method is a paired sam-
ple test. The software package used was WinStar
(Anderson Bell, Arvada, CO), and P9 0.05 was ac-
cepted as statistically signi¢cant.
3. Results and discussion
3.1. Immunoa⁄nity puri¢ed MHC I is incorporated
into large unilamellar vesicles in a native
conformation
MHC I isolated from EL4 (H-2b) cells by a⁄nity
chromatography on M1/42-Sepharose consisted,
under denaturing conditions, of a heavy chain (i.e.
K-chain) with an apparent molecular weight V50
kDa and a 12-kDa light chain (L2m) (Fig. 2). Densi-
tometry of the Coomassie blue-stained gel indicated
the relative densities of these two bands to be 1.3^2.5
(K-chain/L2m), which varied with the puri¢cation lot
and elution fraction. This relative recovery of the
Fig. 2. Electrophoretic properties of immunoa⁄nity puri¢ed
MHC I. MHC I puri¢ed by a⁄nity chromatography was elec-
trophoresed under denaturing conditions in a 14% polyacryl-
amide (resolving) gel, and the gel was stained with Coomassie
brilliant blue R-250. The left lane provides the molecular weight
markers and the right lane shows the trichloroacetic acid-pre-
cipitable protein eluted from the M1/42 a⁄nity column.
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two chains is similar to that presented in the illustra-
tions of Stallcup et al. [25], whose MHC I puri¢ca-
tion procedure is the model upon which our immu-
noa⁄nity method is based. Contaminating bands
constituted 4.5^6.6% of the total mass detected den-
sitometrically, and thus were unlikely to interfere sig-
ni¢cantly with proteoliposome reconstitution. The
incorporation of protein into liposomes was highly
e⁄cient (80% of added protein was incorporated)
and equivalent for di¡erent liposome preparations
(Table 1). Equivalent protein incorporation is impor-
tant (it is assumed in subsequent assays), but not
surprising; saturation of the bilayers with detergent
prior to MHC I addition obviates the in£uence of
the phospholipids on protein insertion.
Fig. 3 demonstrates that £uorescent monoclonal
antibodies directed against Kb will intensely stain
liposomes reconstituted with a⁄nity puri¢ed MHC
I (Fig. 3B), whereas liposomes lacking MHC I are
not stained (Fig. 3D), nor are MHC I-reconstituted
Fig. 3. MHC I reconstituted into proteoliposomes displays speci¢c staining. Egg PC liposomes were reconstituted with MHC I and
stained with FITC-labeled AF6-88.5 (anti-Kb) (A, B) or with FITC-labeled anti-Thy-1 (an irrelevant antibody) (E,F). In C and D,
egg PC liposomes lacking MHC I were stained with FITC-labeled AF6-88.5. A, C, and E display the forward (y-axis) and side
(x-axis) scatter characteristics of the liposomes and illustrate the gating (box) for the corresponding £uorescence histograms in B, D,
and F (x-axis, £uorescence channel; y-axis, number).
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proteoliposomes treated with FITC-anti-Thy-1, an
irrelevant antibody (Fig. 3F). The corresponding
plots of liposome size versus complexity (forward
scatter versus side scatter) are provided in Fig. 3A,
C and E; variations in size (forward scatter) and
trapped internal membranes (side scatter) were likely
introduced during initial liposome formation as well
as subsequent manipulations to insert protein. The
gates shown in Fig. 3A, C, and E are those assigned
to the £uorescence histograms (Fig. 3B,D,F).
Although di¡erent numbers of liposomes were
counted in the three samples (ranging from 2187 to
9641 events), it is clear that intense staining is only
achieved for MHC I-reconstituted proteoliposomes
treated with £uorescent anti-MHC I antibodies.
The reconstitution method, insertion of protein
into pre-formed detergent-saturated liposomes fol-
lowed by rapid detergent removal with Bio-Beads,
was chosen to maximize MHC I rightside-out orien-
tation and non-hairpin conformation. Earlier recon-
stitution methods utilized extensive dialysis starting
with mixed micelles of protein and lipid, and resulted
in proteoliposomes with heterogeneous protein^lipid
ratios and orientations [23] and a putative hairpin
conformation for Kk [24]. In contrast, when pre-
formed liposomes and rapid detergent removal were
used, the protein^lipid ratios were more homogene-
ous and the protein orientation was highly asymmet-
rical, with the protein hydrophobic domain inserted
¢rst into the membrane (i.e. 85^95% of protein mol-
ecules inserted rightside-out) [23]. Although we can-
not completely exclude the possibility that some
MHC I is oriented inside-out, this possibility seems
remote. Furthermore, antibodies, which are large
(s 150 kDa) globular proteins, do not penetrate
the liposomes to stain MHC I and therefore MHC
I with an inside-out orientation would not be ana-
lyzed by £ow cytometry.
Our principal concern was that MHC I may as-
sume a hairpin con¢guration (extracellular domains
and cytoplasmic tail all facing out, Fig. 1); this con-
formation may obscure the e¡ects of membrane lip-
ids and have little biological relevance. Hence, to
assess the likelihood of a hairpin con¢guration for
reconstituted MHC I we used the approach described
Table 1
Protein is incorporated e⁄ciently into preformed 2-Wm liposomesa
Liposomes Protein added (Wg) Protein recovered (Wg) Protein incorporatedb
18:0, 18:1 PC 2.0 1.7 (Expt. 1) 83%
1.6 (Expt. 2) (80^85%)
18:0, 22:6 PC 2.0 1.7 (Expt. 1) 80%
1.5 (Expt. 2) (75^85%)
aPreformed liposomes were incubated with immunoa⁄nity isolated MHC I at a saturating n-octyl-K-D-glucopyranoside concentration.
After detergent removal with Bio-Beads, the liposomes were washed in 15 vols. of PBS and harvested by centrifugation at
100 000Ugmax for 30 min at 4‡C, and the protein was quanti¢ed with a CBQCA protein assay kit.
bThe values for protein incorporated are means of two experiments, with the range shown in parentheses.
Fig. 4. Db, predicted to be lost during a⁄nity chromatography,
is not detected in proteoliposomes. Proteoliposomes reconsti-
tuted with immunoa⁄nity puri¢ed MHC I were treated with
anti-Db monoclonal antibodies (clone 28-14-8S, black histo-
gram) plus FITC-labeled anti-mouse IgG, or with the secondary
antibody alone (gray histogram). Positive staining of the cells
from which the MHC I was obtained is shown in the inset.
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by Cardoza et al. [24] in which MHC I is £uores-
cently labeled on two free sulfhydryl groups (Cys-142
in the extracellular K2-domain and Cys-358 in the
cytoplasmic tail of Kb ; accession no. P01901, The
National Center for Biotechnology Information,
http://www.ncbi.nlm.nih.gov). Once MHC I is in-
serted into liposomes, £uorophore molecules (Cys-
AEDANS) facing out of the liposomes are quenched
by cobalt ion in the bathing solution, whereas £uo-
rophores facing into the liposome interior are not
quenched. Thus, proteins in the non-hairpin con¢g-
uration will display partial (50%) quenching in this
assay, although the method does not distinguish
rightside-out from inside-out orientation. Table 2
demonstrates that approximately half of the total
AEDANS £uorescence is external to the liposome,
consistent with a non-hairpin con¢guration. The
low £uorescence intensities made it di⁄cult to
achieve exacting precision with this assay, but clearly
only partial quenching occurred with intact proteoli-
posomes. This is in stark contrast to the results of
Cardoza et al. [24], who found all £uorescence from
proteoliposomes formed by dialysis to be quenched
externally, i.e. in their study all MHC I was in the
hairpin con¢guration.
EL4 cells were the source for MHC I, and these
cells express both MHC I proteins Kb and Db. The
monoclonal antibody (M1/42) used for a⁄nity puri-
¢cation of MHC I molecules binds MHC I of all
mouse haplotypes, but reportedly does not isolate
Db [26]. Our results, shown in Fig. 4, agree with
[26] ; Db is not detectable on MHC I-reconstituted
proteoliposomes stained with the 28-14-8S antibody,
which recognizes an epitope in the K3-domain of Db.
This antibody is a good choice to monitor Db ex-
pression because it detects a stable epitope whether
L2m is present or absent [27^29] and will bind inde-
pendently of peptide’s in£uence on the K1/K2 do-
mains [2]. Thus, we believe it very likely that failure
of 28-14-8S to stain proteoliposomes indicates that
most if not all MHC I reconstituted into liposomes is
Kb. Further analysis focused on Kb alone.
3.2. Among phospholipids, DHA-containing PC shows
the greatest impact on MHC I expression
measured by monoclonal antibody binding
Kb was reconstituted into liposomes; each lipo-
some preparation contained a single phospholipid
species. With this simpli¢ed model membrane repre-
senting annular lipids or those within lipid microdo-
mains we were able to compare unambiguously the
e¡ect of di¡erent phospholipid species on MHC I.
The left panels in Fig. 5 show the forward scatter
and side scatter characteristics of proteoliposomes
composed of PC with stearic acid (18:0) in the sn-1
position and either oleic acid (18:1g9) or DHA
(22:6g3) in the sn-2 position. In the right panels
are £ow cytometric histograms of phycoerythrin-la-
beled AF6-88.5 monoclonal antibody (anti-Kb) bind-
ing to MHC I in 18:0, 18:1 PC (Fig. 5B) and 18:0,
22:6 PC (Fig. 5D) proteoliposomes. Two independ-
ent experiments were performed with phycoerythrin-
labeled AF6-88.5 and each demonstrated that bind-
Table 2
MHC I in liposomes assumes a native, not hairpin conformation
Experiment Fluorescence intensitya % Quenchb
Unquenched 29 mM CoCl2 50 mM CoCl2 Triton X-100
1 167 53 47 9 76
2 130 80 77 7 43
Average = 60
aImmunoa⁄nity puri¢ed MHC I (Kb) was labeled with IAEDANS, which reacted with free sulfhydryl groups, one in the extracellular
K2-domain and the other in the cytoplasmic tail. The labeled protein was then reconstituted into liposomes composed of egg PC and
unquenched £uorescence was monitored. Quenching of AEDANS external to the bilayer was achieved by the addition of CoCl2 to
the bathing solution. To demonstrate quenching of all AEDANS, Triton X-100 was added to dissolve the liposomes in the presence
of CoCl2.
bThe percent quench was calculated as follows: [1-(£uorescence with 50 mM CoCl2-£uorescence after Triton X-100 dissolution)/(un-
quenched £uorescence-£uorescence after Triton X-100 dissolution)]U100%. Under ideal conditions, 50% quenching will occur when all
MHC I molecules are in the rightside-out, non-hairpin con¢guration.
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ing of monoclonal antibody is greater when Kb is
present in a DHA-containing phospholipid environ-
ment. Fluorescence intensity (antibody binding) was
divided into four levels, from dull to bright, corre-
sponding to the four decades (sets of 256 channels)
of the 1024-channel photomultiplier tube. The per-
cents of liposomes expressing £uorescence intensities
at these four levels (decades) were then calculated.
The percent of proteoliposomes £uorescing in the
third and fourth (brightest) decades ranged from 58
to 72% (decade 3) and 22 to 35% (decade 4) for 18:0,
22:6 PC-proteoliposomes, but only 18% (decade 3)
and 7 to 15% (decade 4) for 18:0, 18:1 PC-proteoli-
posomes. Accordingly, median £uorescence channels
(median £uorescence intensity in all decades) ranged
from 51 to 64 for the DHA-containing and 1 to 4 for
the oleic acid-containing proteoliposomes.
Because we can rule out di¡ering amounts and
orientations of protein present in the two liposome
populations, the most reasonable explanations for
the lipid dependence of Kb expression (shown in
Fig. 5) are, ¢rst, that the lipid environment has
Fig. 5. MHC I expression in proteoliposomes is dependent upon the lipid composition of the bilayer. MHC I was reconstituted into
liposomes composed of PC with stearic acid (18:0) in the sn-1 position and either oleic acid (18:1) or DHA (22:6) in the sn-2 posi-
tion, and analyzed by £ow cytometry. Forward and side scatter characteristics of the proteoliposomes are shown in the left panels:
(A) 18:0, 18:1 PC proteoliposomes; (C), 18:0, 22:6 PC proteoliposomes. The corresponding £uorescence histograms for the boxed
(gate A) proteoliposomes are shown in B (18:0, 18:1 PC proteoliposomes) and D (18:0, 22:6 PC proteoliposomes). Shown on these
histograms are linear gates B^E representing the four decades of £uorescence intensity, as well as the percent of liposomes in each
gate. Proteoliposome staining was with phycoerythrin-labeled AF6-88.5 (anti-Kb) monoclonal antibody.
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changed the conformation of Kb thereby a¡ecting
the expression of the AF6-88.5 epitope and, second,
that the MHC I proteins are self aggregating in the
18:0, 18:1 PC bilayer, thereby obscuring the binding
of antibodies. Of course, these two processes are not
mutually exclusive and may both be operative. Self
aggregation of free MHC I heavy chains (K-chains
dissociated from L2m) has been reported, and having
Kb epitopes in close proximity may sterically hinder
binding of the monoclonal antibodies or bring to-
gether £uorophore molecules, such that £uorophore
self quenching occurs. Phycoerythrin is relatively re-
sistant to self quenching [30] and thus self quenching
is unlikely to be at play in the experiment shown in
Fig. 5. Fluorescein, on the other hand, is quite sen-
sitive to self quenching, and £uorescein-conjugated
antibodies were used in various aspects of this study.
We therefore addressed the participation of MHC I
self aggregation in our system. Chakrabarti et al. [9]
reported that human MHC I reconstituted into di-
myristoylphosphatidylcholine (14:0, 14:0 PC) dis-
played self aggregation (measured by FRET), which
could be blocked with exogenous L2m. Note, how-
ever, that 14:0, 14:0 PC is not typically found in
mammalian plasma membranes and does not pro-
duce the usual surface bilayer thickness; this results
in a hydrophobic mismatch between the bilayer and
the protein’s transmembrane region and promotes
protein oligomerization to minimize exposed hydro-
phobic area [31]. EL4 cells (our source for Kb) re-
portedly express Vone-third of their surface MHC I
molecules as free K-chains, which are created on the
cell surface by L2m loss [32]. It is possible that 18:0,
18:1 PC proteoliposomes have a higher proportion
of free K-chains, which in turn may cause less anti-
body to bind to 18:0, 18:1 PC compared to 18:0,
22:6 PC proteoliposomes. To test this hypothesis,
exogenous human L2m (which binds avidly to mur-
ine MHC I [33]), was added to the proteoliposomes
prior to staining with FITC-AF6-88.5. When human
L2m, either as a puri¢ed protein or in human serum,
was added to the proteoliposomes, FITC-AF6-88.5
binding was enhanced 14^53% (consistent with some
exchange between endogenous and added L2m, or
addition of L2m to free K-chains), however, this
treatment did not equalize antibody binding to Kb
in 18:0, 18:1 PC and 18:0, 22:6 PC, nor was the
greatest enhancement associated with the 18:0, 18:1
PC environment (Table 3). The presence of L2m in
the protein used for reconstitution (Fig. 2) and the
failure of L2m addition to equalize £uorescence pro-
vided no compelling reason to pursue self aggrega-
tion of MHC I free K-chains as the reason for dis-
parate antibody binding.
We explored the expression of Kb in various lipid
environments, namely, PC with stearic acid in the sn-
1 position and either oleic acid (18:1g9), K-linolenic
acid (18:3g3), arachidonic acid (20:4g6) or DHA
(22:6g3) in the sn-2 position. The ‘control’ bilayer
is formed from 18:0, 18:1 PC, which is a phospho-
Table 3
L2m addition does not equalize monoclonal antibody binding to proteoliposomes of disparate lipid composition
Liposome L2ma % of Liposomes in: Relative % increaseb
Decade 1 Decade 2 Decade 3 Decade 4
Experiment 1
18:0, 18:1 PC 3 62.7 4.8 13.6 19.0
18:0, 18:1 PC + 50.1 9.9 18.2 21.6 14
18:0, 22:6 PC 3 43.8 8.9 21.3 26.3
18:0, 22:6 PC + 27.9 10.9 22.1 38.9 48
Experiment 2
18:0, 18:1 PC 3 78.2 2.6 4.3 14.9
18:0, 18:1 PC + 75.2 0.6 2.3 21.9 47
18:0, 22:6 PC 3 64.4 3.2 5.2 27.2
18:0, 22:6 PC + 51.4 1.3 5.8 41.6 53
aProteoliposomes were pretreated with either puri¢ed human L2m (Expt. 1) or ¢ltered human serum (Expt. 2) and then stained with
FITC-AF6-88.5.
bTo assess an e¡ect of L2m addition, appearance of proteoliposomes with the brightest £uorescence (Decade 4) was monitored, and
the relative % increase calculated as 100%U[(% in Decade 4 with L2m)3(% in Decade 4 without L2m)]/(% in Decade 4 without L2m).
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lipid molecular species among the most abundant in
leukocyte membranes [34] and which contains oleic
acid, a monounsaturated fatty acid. In contrast,
DHA has 22 carbons and six double bonds, the
last of which is three carbons from the methyl (ome-
ga) end, hence the name ‘omega-3’. It is the longest
and most unsaturated fatty acid found in abundance
in biological systems and its tissue levels are altered
substantially by diet [35]. K-Linolenic acid, like
DHA, is an omega-3 fatty acid; it is a precursor
for the synthesis of longer, more polyunsaturated
omega-3 fatty acids, such as DHA and typically
does not accumulate in substantial amounts in mem-
branes. Arachidonic acid is a long chain polyunsatu-
rated fatty acid, but with two fewer carbons and
double bonds than DHA, and its last double bond
is six carbons from its methyl end (‘omega-6’). Like
DHA, arachidonic acid is found in phospholipids,
such as phosphatidylserine, phosphatidylethanol-
amine, and PC [36,37] and enrichment of membranes
with DHA typically produces a concomitant decrease
in arachidonic acid content [34,38,39] ; thus, these
two fatty acids may compete for the same position
in cellular membrane phospholipids. Fluorescein-la-
beled AF6-88.5 was used to probe for di¡erences in
expression of MHC I in the di¡erent liposomes. As
shown in Table 4, DHA-containing PC provided for
signi¢cantly greater binding of £uorescein-labeled
AF6-88.5 to Kb when compared to all other lipids
tested. Parenthetically, the experimental procedures
represented by the data in Tables 3 and 4 are not
identical and thus trends, rather than absolute £uo-
rescence intensities, are compared; all statistical anal-
yses were performed with a non-parametric, paired
sample test. The mean (30.2) and median (22.5) £uo-
rescence channels for 18:0, 22:6 PC proteoliposomes
were signi¢cantly higher than the other proteolipo-
somes, resulting from a signi¢cantly greater percent-
age of proteoliposomes with £uorescence in the third
decade and concomitantly fewer in the ¢rst decade.
Proteoliposomes composed of 18:0, 18:3 PC and
18:0, 20:4 PC displayed £uorescence intensities that
were not signi¢cantly di¡erent from each other, but
that showed distinct di¡erences from 18:0, 22:6 PC.
As each proteoliposome population is composed of
only the immunoa⁄nity-isolated Kb and a single lip-
id species, it must be a direct e¡ect of the lipid on the
protein causing di¡erences in antibody binding and
£uorescence.
3.3. E¡ects of 18:0, 22:6 PC on other MHC I
epitopes
Two other FITC-conjugated monoclonal antibod-
ies were tested for their ability to bind Kb in the
control (18:0, 18:1 PC) and the DHA-containing
(18:0, 22:6 PC) lipid environments. Based on haplo-
type speci¢city, each antibody detects an epitope dis-
tinct from AF6-88.5. That is, whereas AF6-88.5 re-
acts with an epitope expressed by the b haplotype
and weakly expressed by H-2k, CTKb reacts with a
private Kb speci¢city and 5041.16.1 detects a specif-
icity shared by Kb and Db (speci¢cities provided by
the manufacturers). Proteoliposome staining by
CTKb and 5041.16.1 is approximately 10-fold less
than with AF6-88.5, although live EL4 cells stain
Table 4
DHA-containing PC favors the binding of monoclonal antibody AF6-88.5
Proteoliposome Fluorescence channel % of Liposomes in:
Mean Median Decade 1 Decade 2 Decade 3 Decade 4
18:0, 18:1 PC 22.4 þ 13.1a 15.2 þ 12.6a 28.2 þ 15.9a 33.2 þ 12.5a;b 33.3 þ 12.3a 5.6 þ 4.6a
18:0, 18:3 PC 7.8 þ 0.5a 4.0 þ 0.7a 13.5 þ 4.6a;b 59.0 þ 7.8c 22.9 þ 7.1a 0.4 þ 0.4b
18:0, 20:4 PC 18.9 þ 10.6a 14.0 þ 9.0a 8.5 þ 3.3b 51.6 þ 13.9b;c 37.2 þ 13.7a 3.2 þ 2.9a;b
18:0, 22:6 PC 30.2 þ 12.2b 22.5 þ 12.0b 5.3 þ 2.2b 33.2 þ 12.3a 56.4 þ 11.7b 5.4 þ 3.9a
MHC I-reconstituted liposomes of various phospholipid compositions were stained with £uorescein-conjugated AF6-88.5 (anti-Kb)
and analyzed by £ow cytometry. Antibody binding is expressed as mean and median £uorescence intensity channel, and the percent
of liposomes having £uorescence in Decade 1 (channels 0^255), decade 2 (256^511), decade 3 (512^767), and decade 4 (768^1023) on
a four-decade, 1024-channel log scale.
aÿdSigni¢cantly di¡erent values within a column are denoted by di¡erent superscript letters (P90.05, Wilcoxon paired sample test).
The data are presented as means þ S.E. (n = 4 independent experiments for all lipids except 18:0, 18:3 PC where n = 3).
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equivalently with all antibodies (data not shown).
However, even moderately stained, DHA-containing
proteoliposomes treated with FITC-conjugated
CTKb antibodies were signi¢cantly more £uorescent
than the 18:0, 18:1 PC-proteoliposomes, as judged
by mean and median £uorescence intensity and the
percent of proteoliposomes distributed in the four
decades of £uorescence intensity (Table 5). The dif-
ference between 18:0, 22:6 PC and 18:0, 18:1 PC
proteoliposomes stained with FITC-labeled
5041.16.1 antibodies was equivocal, with statistical
signi¢cance achieved only for comparisons of mean
£uorescence intensity and percent of proteoliposomes
with decade 3-level £uorescence intensity. It would
thus appear that three epitopes (detected by three
distinct monoclonal antibodies) are not a¡ected iden-
tically by the DHA-containing lipid environment,
hinting that DHA may induce a conformational
change in Kb wherein some portions of the molecule,
i.e. epitopes, are altered while others are not.
The epitope to which the AF6-88.5 monoclonal
antibody binds was reported to be in the K2-domain
of Kb [40], but more recently it was found to be a
conformational determinant sensitive to amino acid
substitutions in all three K-chain extracellular do-
mains as well as the source of L2m [41]. It is there-
fore not surprising to us that the greatest e¡ect of
DHA-containing PC was on this conformationally
sensitive epitope. The K1 and K2 extracellular do-
mains most distal from the membrane are particu-
larly prone to change conformation, consistent with
their role in antigen binding and presentation. For
example, the K1/K2-epitope on Dd detected with
monoclonal antibody 34-5-8S disappears more
quickly than an epitope in the K3-domain (detected
by 34-2-12S) upon loss of L2m [42]. However, a key
consideration is whether interactions between a
membrane protein (presumably at its transmembrane
region) and phospholipids in the membrane bilayer
can produce conformational changes in distant pro-
tein domains. Dissociation of L2m from the extracel-
lular domains of either murine or human MHC I
produces a conformational change that exposes epi-
topes in the cytoplasmic tail [10,32]. These are impor-
tant ¢ndings because they imply that conformational
changes can be telegraphed through the K-chain.
Can changes in MHC I conformation induced by
the lipid composition of membranes a¡ect MHC I
function, i.e. presentation of antigen? Lipids added
to MHC class II molecules in detergent a¡ected ra-
diolabeled peptide binding by MHC II, suggesting
that lipids may induce, perhaps indirectly, a confor-
mational change in the peptide binding groove of
this MHC molecule [43]. Early studies germane to
MHC I noted that resistance to killing by cytotoxic
T-lymphocytes correlated with reduced PC synthesis
and increased cholesterol content [44], conditions
that reduced the apparent expression of certain
MHC I epitopes [16,17]. Because the K1/K2 surface
of the MHC I contacts the TCR, the propensity for
conformational change in that portion of the MHC I
could sway the repertoire of T-cell clones activated
during an immune response. Relatively minor con-
formational changes in MHC I are thought to mask
epitopes recognized by, and which inhibit, activated
natural killer cells [45]. Recently, the transmembrane
Table 5
Binding of monoclonal antibodies to other MHC I epitopes is modestly but signi¢cantly a¡ected by DHA-containing PC
Proteoliposome Fluorescence channel % of Liposomes in:
Mean Median Decade 1 Decade 2 Decade 3 Decade 4
Monoclonal antibody CTKb
18:0, 18:1 PC 2.0 þ 0.9 0.8 þ 0.7 61.4 þ 12.4 34.7 þ 9.7 3.8 þ 2.9 0.0 þ 0.0
18:0, 22:6 PC 5.0 þ 1.5a 4.6 þ 1.6a 19.0 þ 4.3a 65.9 þ 3.2a 14.9 þ 7.2a 0.0 þ 0.0
Monoclonal antibody 5041.16.1
18:0, 18:1 PC 2.7 þ 0.7 0.2 þ 0.1 78.1 þ 10.2 13.4 þ 6.0 8.0 þ 6.0 0.2 þ 0.1
18:0, 22:6 PC 4.6 þ 1.6a 2.7 þ 2.5 62.7 þ 23.6 23.5 þ 14.7 12.1 þ 9.4a 0.4 þ 0.3
MHC I-reconstituted liposomes were stained with £uorescein-labeled monoclonal antibodies CTKb and 5041.16.1, and analyzed by
£ow cytometry. Decades are de¢ned in the legend to Table 3.
aSigni¢cant di¡erence (P90.05) between 18:0, 18:1 PC and 18:0, 22:6 PC proteoliposomes, as tested with the non-parametric Wilcox-
on paired sample test. The data are means þ S.E. (n = 3 for each monoclonal antibody).
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region of human MHC I was found to be responsible
for inhibiting certain natural killer clones through an
undetermined mechanism likely to involve control of
protein conformation rather than MHC I oligomeri-
zation, association with other proteins, or cellular
localization [46]. We therefore consider it an essential
next step to test the T-cell activating ability of MHC
I proteoliposomes of various lipid compositions. Ad-
ditionally, we are currently undertaking additional
assays of conformational change of MHC I reconsti-
tuted into liposomes. By understanding the direct
e¡ect of DHA-containing phospholipids on MHC I
properties, such as conformation and antigen presen-
tation, we hope not only to better predict the e¡ects
of DHA in vivo (e.g. when provided in the diet), but
also to devise novel immunotherapies that utilize
DHA’s abilities to in£uence antigen presentation.
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